Logo image of ZCMD

ZHONGCHAO INC-CLASS A (ZCMD) Stock Fundamental Analysis

NASDAQ:ZCMD - KYG9897X1152 - Common Stock

0.98 USD
+0 (+0.48%)
Last: 8/27/2025, 7:26:06 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ZCMD. ZCMD was compared to 71 industry peers in the Diversified Consumer Services industry. While ZCMD has a great health rating, there are worries on its profitability. ZCMD is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ZCMD has reported negative net income.
In the past year ZCMD has reported a negative cash flow from operations.
In multiple years ZCMD reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: ZCMD reported negative operating cash flow in multiple years.
ZCMD Yearly Net Income VS EBIT VS OCF VS FCFZCMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M

1.2 Ratios

ZCMD has a Return On Assets of -2.48%. This is comparable to the rest of the industry: ZCMD outperforms 46.48% of its industry peers.
ZCMD's Return On Equity of -3.09% is in line compared to the rest of the industry. ZCMD outperforms 52.11% of its industry peers.
Industry RankSector Rank
ROA -2.48%
ROE -3.09%
ROIC N/A
ROA(3y)-18.84%
ROA(5y)-8.61%
ROE(3y)-25.29%
ROE(5y)-12.23%
ROIC(3y)N/A
ROIC(5y)N/A
ZCMD Yearly ROA, ROE, ROICZCMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

Looking at the Gross Margin, with a value of 56.18%, ZCMD is in the better half of the industry, outperforming 71.83% of the companies in the same industry.
In the last couple of years the Gross Margin of ZCMD has declined.
The Profit Margin and Operating Margin are not available for ZCMD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 56.18%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.01%
GM growth 5Y-3.95%
ZCMD Yearly Profit, Operating, Gross MarginsZCMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

8

2. Health

2.1 Basic Checks

ZCMD does not have a ROIC to compare to the WACC, probably because it is not profitable.
ZCMD has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ZCMD has been increased compared to 5 years ago.
There is no outstanding debt for ZCMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ZCMD Yearly Shares OutstandingZCMD Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ZCMD Yearly Total Debt VS Total AssetsZCMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

An Altman-Z score of 3.96 indicates that ZCMD is not in any danger for bankruptcy at the moment.
The Altman-Z score of ZCMD (3.96) is better than 81.69% of its industry peers.
ZCMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.96
ROIC/WACCN/A
WACC7.62%
ZCMD Yearly LT Debt VS Equity VS FCFZCMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 12.22 indicates that ZCMD has no problem at all paying its short term obligations.
ZCMD has a better Current ratio (12.22) than 97.18% of its industry peers.
ZCMD has a Quick Ratio of 11.84. This indicates that ZCMD is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of ZCMD (11.84) is better than 97.18% of its industry peers.
Industry RankSector Rank
Current Ratio 12.22
Quick Ratio 11.84
ZCMD Yearly Current Assets VS Current LiabilitesZCMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 98.62% over the past year.
Looking at the last year, ZCMD shows a very negative growth in Revenue. The Revenue has decreased by -18.37% in the last year.
Measured over the past years, ZCMD shows a small growth in Revenue. The Revenue has been growing by 1.29% on average per year.
EPS 1Y (TTM)98.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96.29%
Revenue 1Y (TTM)-18.37%
Revenue growth 3Y-0.89%
Revenue growth 5Y1.29%
Sales Q2Q%-17.02%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ZCMD Yearly Revenue VS EstimatesZCMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

0

4. Valuation

4.1 Price/Earnings Ratio

ZCMD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZCMD Price Earnings VS Forward Price EarningsZCMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ZCMD is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 162.44
ZCMD Per share dataZCMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ZCMD!.
Industry RankSector Rank
Dividend Yield N/A

ZHONGCHAO INC-CLASS A

NASDAQ:ZCMD (8/27/2025, 7:26:06 PM)

0.98

+0 (+0.48%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)10-04 2022-10-04/dmh
Earnings (Next)12-13 2022-12-13/dmh
Inst Owners0.12%
Inst Owner Change0%
Ins Owners0.19%
Ins Owner ChangeN/A
Market Cap24.88M
Analysts0
Price TargetN/A
Short Float %1.07%
Short Ratio0.73
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.57
P/FCF N/A
P/OCF N/A
P/B 1.19
P/tB 1.19
EV/EBITDA 162.44
EPS(TTM)-0.06
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0.62
BVpS0.82
TBVpS0.82
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.48%
ROE -3.09%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 56.18%
FCFM N/A
ROA(3y)-18.84%
ROA(5y)-8.61%
ROE(3y)-25.29%
ROE(5y)-12.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.01%
GM growth 5Y-3.95%
F-Score4
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 710.83%
Cap/Sales 19.19%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 12.22
Quick Ratio 11.84
Altman-Z 3.96
F-Score4
WACC7.62%
ROIC/WACCN/A
Cap/Depr(3y)431.45%
Cap/Depr(5y)380.13%
Cap/Sales(3y)11.64%
Cap/Sales(5y)9.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96.29%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-18.37%
Revenue growth 3Y-0.89%
Revenue growth 5Y1.29%
Sales Q2Q%-17.02%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y93.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-475.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2818.08%
OCF growth 3YN/A
OCF growth 5YN/A